·
Where to Get Ibogaine Treatment: The Legal Map
Where to get ibogaine treatment, answered with law rather than names. No directory, no provider, no referral fee. Unscheduled rarely means permitted.
We keep no directory, take no money from any provider, and will not point you at one. What we can give you is the part that actually protects you: where ibogaine can lawfully be given, under which instrument, and why unscheduled almost never means permitted.
Most pages answering this query are selling something. This one is a legal map and a method, and it starts by explaining the refusal.
Searches for where to get ibogaine treatment, how to get it, and clinics near me all resolve to the same two questions: where can it lawfully be given, and how do you tell a careful provider from a careless one. Neither is answered by a list.
Why there is no list here
A directory is a referral, and a referral is a recommendation whatever it calls itself. There is no way to publish one honestly, for three reasons that are all established elsewhere on this site.
Nobody accredits ibogaine providers. Not a professional body, not a regulator. The organisation whose guidelines the sector cites is in strike-off proceedings and its own text says it is not a standard. How to evaluate a clinic sets that out.
There is no outcome data to rank anyone on. No provider publishes verified outcomes and no study compares them.
And the reviews do not work. Ratings of surgeons show no correlation with their risk-adjusted death rates, and self-published testimonials are a selection rather than a sample.
So a directory would sort providers by marketing. That is worse than nothing.
The legal map
The distinction that matters in almost every country is not the drug law. It is the medicines law.
| Jurisdiction | Drug-law status | What actually binds |
|---|---|---|
| United States | Schedule I | Prohibited. Federal prosecution has followed a death |
| New Zealand | Not a controlled drug | Prescription medicine. Lawful via an unapproved-medicine route |
| Australia | Not prohibited | Schedule 4, prescription only, and an import licence is required |
| Canada | Not scheduled under drug law | On the Prescription Drug List since 2017, and not authorised for use |
| Mexico | Unscheduled | Medicines law. An unregistered medicine, unlawfully advertised |
| South Africa | Schedule 6, prescription | Every preparation must be registered. None is |
| Costa Rica | Not established | Health ministry has publicly called the practice unauthorised |
| Brazil | Not scheduled | Medicines and professional regulation |
| Portugal | Not scheduled, and decriminalisation does not reach it | Administering it without authorisation is an offence |
Where ibogaine is legal covers each of these in detail.
This is the single most misunderstood point in the subject, and clinics rely on the confusion.
Mexico is the clearest case. Ibogaine is genuinely absent from the schedules of the general health law, so administering it is not a drug offence. But it meets that same law’s definition of a medicine, which turns on therapeutic purpose. No ibogaine product holds the sanitary registration the law requires. And advertising a product without that authorisation breaches a separate provision, with its own penalty.
So “unregulated in Mexico” is false as usually stated. What is absent is not the law. It is enforcement, and enforcement is not something you can rely on when something goes wrong at three in the morning.
The two ends of the range
The United States. Ibogaine is Schedule I. In 2025 a man was sentenced to 48 months for distributing ibogaine, in a case where the court found at sentencing that the ibogaine he distributed caused a person’s death. The prosecutor’s statement is blunt: ibogaine is dangerous, and taking it can have deadly consequences.
That is why treatment happens elsewhere, and it is worth understanding what travelling means. You are buying a medical service in a country where you have no regulator to complain to, no medical board with jurisdiction over you, and generally no legal recourse.
New Zealand. The only jurisdiction where it can be prescribed. The classification committee recommended it in 2009 on an explicit rationale: the treatment needs supervision, and prescription status would limit self-treatment. It carries a real audit trail, with a monthly written report to the Director-General on supply of unapproved medicines and record-keeping at patient level.
New Zealand is also where a regulator found that a clinic did not operate safely after a woman died in 2013, with one page of written procedures and a dose given well above the clinic’s own limit.
Note what that same decision records: ibogaine was imported and supplied to the doctor in accordance with the requirements of the Medicines Act. The legal chain worked exactly as designed and a woman still died.
And the only published outcome study from that country reports, of fourteen participants, that one patient died during treatment.
How to get ibogaine treatment, if you are going anyway
We are not going to talk anyone out of a decision they have made. What follows is the sequence that separates a survivable arrangement from a dangerous one, and it is the same sequence wherever you go.
What to do instead of searching for a name
If you are going to do this, the useful work is not finding a provider. It is being able to tell one from another, and that is a set of questions rather than a list.
Before anything else, talk to whoever prescribes your current medication. Every published protocol requires you to stop things, and that washout is part of the intervention with its own risk. What a treatment involves sets out what is typically required.
Then ask the questions that have factual answers. How many hours of continuous cardiac monitoring, how many leads, who is awake at four in the morning, how far to a hospital that can treat an arrhythmia, and may I read the written protocol before I travel. How to evaluate a clinic is that list, and red flags is what a bad answer looks like.
And weigh the alternative honestly. If this is for opioid dependence, the counterfactual is not nothing. Opioid agonist treatment is the only intervention shown to reduce overdose deaths, and leaving it for an unproven one has been written about by addiction physicians as a specific risk. After treatment covers why.
What we will never publish
No clinic names as recommendations, no affiliate links, no referral arrangements, no lead generation, and no source of supply in any jurisdiction.
That is not squeamishness. Every one of those is how the rest of this subject is funded, and it is the reason almost nothing else you will read about finding treatment is disinterested.
Common questions
Sources
4 sources · How we source
- Broomfield man sentenced to 48 months for ibogaine distribution
Primary source · United States Attorney's Office, District of Colorado, 2025 · accessed 28 Aug 2026
- Minutes of the 42nd meeting of the Medicines Classification Committee
Primary source · Medsafe, New Zealand, 2009 · accessed 28 Aug 2026
- Monitoring of patient following administration of an unapproved, prescription-only medication (13HDC00966)
Primary source · Health and Disability Commissioner, New Zealand, 2015 · accessed 28 Aug 2026
- Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Primary source · American Journal of Drug and Alcohol Abuse, 2018 · accessed 28 Aug 2026